Indian Immunologicals gets DCGI nod for Measles-Rubella vaccine
Vaccine maker Indian Immunologicals (IIL) has received approval from the Drugs Controller General of India (DGCI) and Telangana State Drug Control Administration (DCA) for manufacturing Measles-Rubella (MR) vaccine. IIL is collaborating with Vietnam's Center for Research and Production of Vaccines and Biologicals, also known as Polyvac.
Published 2 months ago · Viet Nam
News Articles
More Filters
All
Left
Center
Right
Time & Location
Sources are mostly out of (0)